ARCHIVES

Cancer Control Planning Completed, Going Through Final Review Process

This article is from The Cancer Letter archive.

Vol. 01 No. 23 | July 12, 1974

Download PDF Visit The Full Archive

Related Articles

13th Congress Advance Program Announcement Now Available

May 1, 1981

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001